Approval · Notice of Compliance 21712 · 2019
LUTATHERA: Notice of Compliance 21712
Issued January 9, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21712
- Date
- January 9, 2019
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUTATHERA | 02484552 | Marketed |
Medicinal ingredients
- LUTETIUM (177LU) OXODOTREOTIDE 370 MBQ per ML